Correction: Ixekizumab Efficacy in Patients with Severe Peripheral Psoriatic Arthritis: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (SPIRIT-P1)
Rheumatol Ther. 2024 May 16.
doi: 10.1007/s40744-024-00673-2.
Online ahead of print.
1 Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University, Tokyo, Japan.
2 Eli Lilly Japan K.K., Kobe, Hyogo, Japan.
3 Eli Lilly and Company, Indianapolis, IN, USA.
4 Eli Lilly Japan K.K., Kobe, Hyogo, Japan. konomi_ayako@lilly.com.
5 Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan.